tiprankstipranks
Trending News
More News >
Immuno-Biological Laboratories Co., Ltd. (JP:4570)
:4570
Japanese Market

Immuno-Biological Laboratories Co., Ltd. (4570) Financial Statements

Compare
0 Followers

Immuno-Biological Laboratories Co., Ltd. Financial Overview

Immuno-Biological Laboratories Co., Ltd.'s market cap is currently ¥4.87B. The company's EPS TTM is ¥12.42; its P/E ratio is 18.92; Immuno-Biological Laboratories Co., Ltd. is scheduled to report earnings on May 14, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue¥ 969.53M¥ 816.70M¥ 794.62M¥ 647.58M¥ 602.75M
Gross Profit¥ 628.34M¥ 517.29M¥ 526.71M¥ 376.70M¥ 346.86M
Operating Income¥ 209.35M¥ 104.30M¥ 58.37M¥ -122.22M¥ -240.98M
EBITDA¥ 226.55M¥ 128.11M¥ -332.00M¥ -249.50M¥ -309.88M
Net Income¥ 249.05M¥ 186.69M¥ -289.73M¥ -258.77M¥ -318.83M
Balance Sheet
Cash & Short-Term Investments¥ 825.73M¥ 734.14M¥ 614.16M¥ 508.35M¥ 604.19M
Total Assets¥ 1.85B¥ 1.62B¥ 1.43B¥ 1.71B¥ 1.84B
Total Debt¥ 204.23M¥ 235.98M¥ 234.99M¥ 234.00M¥ 90.00M
Net Debt¥ -621.50M¥ -498.15M¥ -379.17M¥ -274.35M¥ -514.19M
Total Liabilities¥ 331.03M¥ 353.27M¥ 355.72M¥ 336.99M¥ 208.76M
Stockholders' Equity¥ 1.51B¥ 1.27B¥ 1.08B¥ 1.37B¥ 1.63B
Cash Flow
Free Cash Flow¥ 123.83M¥ 115.11M¥ 26.46M¥ -93.20M¥ -207.60M
Operating Cash Flow¥ 183.50M¥ 133.78M¥ 26.46M¥ -93.20M¥ -194.15M
Investing Cash Flow¥ -53.66M¥ -24.50M¥ 30.04M¥ -155.63M¥ -17.23M
Financing Cash Flow¥ -31.75M¥ 991.00K¥ 991.00K¥ 144.00M¥ -216.00M
Currency in JPY

Immuno-Biological Laboratories Co., Ltd. Earnings and Revenue History

Immuno-Biological Laboratories Co., Ltd. Debt to Assets

Immuno-Biological Laboratories Co., Ltd. Cash Flow

Immuno-Biological Laboratories Co., Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis